Pharmaceutical - Inflammatory diseases


Current filters:

Inflammatory diseases

Popular Filters

51 to 53 of 53 results

Compugen links with DiscoveRx on novel peptide ligands for GPCR drug targets


Israel’s Compugen (Nasdaq: CGEN) and USA-based DiscoveRx have entered into a partnership for the…

Cardio-vascularCompugenDiscoveRxInflammatory diseasesPharmaceuticalResearch

Mundipharma commits over $50 million in R&D funding for Infinity’s PI3K inhibitor


Privately-held Mundipharma International as committed to providing over $50 million in funding in 2013…

FinancialInfinity PharmaceuticalsInflammatory diseasesLicensingMundi InternationalOncologyPharmaceuticalResearch

51 to 53 of 53 results

Back to top